Original ResearchTrends in incidence of thick, thin and in situ melanoma in Europe
Introduction
The incidence of cutaneous malignant melanoma has increased steeply since the Second World War [1], [2], [3], [4], [5], [6], [7] although recent observations show a stabilisation of rates in North America and Australia [2]. In these countries, prevention campaigns and interventions aimed at early diagnosis have been implemented, with the aims of limiting solar exposure (especially at younger ages) and of detecting suspicious lesions as early as possible. However, a clear decrease in melanoma mortality in all age groups [8], [9], [10], [11] has not yet been observed.
Some countries have recently noted evidence of decrease in the incidence of invasive melanoma. However the reasons for the decline are not clear from the data and may be due to sun prevention campaigns or earlier diagnosis or both. An important element in understanding the trends is the concurrent behaviour of in situ, thin and thick lesions. Some studies have shown that the incidence of in situ and thin melanomas has been increasing faster than that of thick melanomas [9], [12], [13], [14], [15], [16], [17], [18], [19].
At present, information on the incidence of in situ, thin and thick lesions is collected by many cancer registries in Europe, but statistics on thickness are not available on a routine basis from most of the public access sites. In addition, published studies often focus on the national burden of the disease, lacking a broader European perspective.
This article investigated melanoma incidence and mortality in 13 European countries during the period 1995–2012. To better understand trends, analyses were performed by country, age, sex and Breslow thickness.
Section snippets
Materials and methods
Individual anonymised incidence data (with corresponding population files) were collected from population-based European cancer registries (CRs) through an ad hoc call. CRs directors and researchers received the study protocol by e-mail by the end of year 2015. CRs were selected on the basis of a long history of high-quality data (as proven by inclusion in the last two editions of Cancer Incidence in Five Continents, low percentages of DCO and high proportions of MV for melanoma); at least ten
Results
Our database covered a population of over 117 million inhabitants and included about 415,000 skin lesions, recorded by 18 European CRs (7 of them with national coverage) in 13 countries, between 1995 and 2012 (Table 1). Incidence rates of invasive melanoma in men varied from a low of 5.6 per 100,000 in Tarragona, Spain to 24/100,000 in Geneva, Switzerland, where the highest rate of in situ lesions was also observed, 23/100,000 in men in 2012 (Table 1). Incidence rates were higher among females
Discussion
Melanoma incidence trends in Europe have been previously analysed at a national level [3], [8], [9], [10], [14], [15], [16], [17], [18], [19], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34]. However, the different periods considered and methods used have hampered comparisons between countries. Moreover, differences in incidence and mortality trends in both time and space have made it difficult to interpret mortality-incidence ratios, which are often used as a proxy for
Conflict of interest statement
None declared.
Contributors
TIM (Trends in Melanoma) Working Group
Austrian Cancer Registry (Austria): Monika Hackl, Henrike Karim-Kos; Belgium Cancer Registry (Belgium): Lisbeth Van Eycken; Schleswig–Holstein Cancer Registry (Germany): Alexander Katalinic, Miriam Holzmann; Iceland Cancer Registry (Iceland): Laufey Tryggvadóttir, Elinborg Ólafsdóttir; Ireland Cancer Registry (Ireland): Harry Comber; Piedmont Cancer Registry. (Italy): Roberto Zanetti, Stefano Rosso, Lidia Sacchetto, Paolo Broganelli; Ragusa Cancer Registry
Acknowledgements
Lidia Sacchetto presented this work at the IACR Meeting 2016 in Marrakesh (Morocco) and has been awarded the “Enrico Anglesio” Prize, offered by the Anglesio Moroni Foundation, Turin, Italy. This study was supported by a research grant (grant number 2015.AI329.U390) of the Fondazione Cassa di Risparmio di Torino, Turin, Italy; the grant funded a one-year scholarship to LS. The authors would like to thank the TIM WG (Trends in Melanoma Working Group) members for contributing to this study with
References (44)
- et al.
Increasing burden of melanoma in the United States
J Invest Dermatol
(2009 Jul) - et al.
Are we seeing the effects of public awareness campaigns? A 10-year analysis of Breslow thickness at presentation of malignant melanoma in the South West of England
J Plast Reconstr Aesthetic Surg
(2014 Mar) - et al.
Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland
Eur J Cancer
(2009) - et al.
The characterization and potential impact of melanoma cases with unknown thickness in the United States' Surveillance, Epidemiology, and End Results Program, 1989–2008
Cancer Epidemiol
(2013 Feb) - et al.
Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989
Ann Oncol
(2012 Feb) - et al.
Incidence and survival in patients with cutaneous melanoma by morphology, anatomical site and TNM stage: a Danish Population-based Register Study 1989–2011
Cancer Epidemiol
(2015 Feb) - et al.
Disparities in melanoma incidence and mortality in South-Eastern Europe: increasing incidence and divergent mortality patterns. Is progress around the corner?
Eur J Cancer
(2016 Mar) - et al.
Increasing time trends of thin melanomas in The Netherlands: what are the explanations of recent accelerations?
Eur J Cancer
(2015 Dec) - et al.
The forthcoming inexorable decline of cutaneous melanoma mortality inlight-skinned populations
Eur J Cancer
(2015) - et al.
More people die from thin melanomas (≤ 1mm) than from thick melanomas (> 4mm) in Queensland, Australia
J Invest Dermatol
(2015 Apr)
Miscoding of melanoma thickness in SEER: research and clinical implications
J Invest Dermatol
European code against cancer 4th edition: ultraviolet radiation and cancer
Cancer Epidemiol
Fifty years of cancer incidence: CI5 I-IX
Int J Cancer
International trends in the incidence of malignant melanoma 1953–2008 – are recent generations at higher or lower risk?
Int J Cancer
Burden of disease due to cutaneous melanoma has increased in The Netherlands since 1991
Br J Dermatol
Melanoma epidemic: an analysis of six decades of data from the Connecticut tumor registry
J Clin Oncol
Estimates of cancer burden in Piedmont and Aosta valley
Tumori
Rising trends in incidence of cutaneous malignant melanoma and their future projections in Catalonia, Spain: increasing impact or future epidemic?
J Eur Acad Dermatol Venereol
Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015
J Eur Acad Dermatol Venereol
Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence
Melanoma Res
Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study
JAMA Dermatol
Trends for in situ and invasive melanoma in Queensland, Australia, 1982–2002
Cancer Causes Control
Cited by (141)
Epidemiological transition of primary cutaneous melanoma in a public hospital in Brazil (1999–2019)
2023, Anais Brasileiros de DermatologiaLentigo maligna: a review
2024, Clinical and Experimental DermatologyFactors associated with the melanoma diagnostic interval in Ontario, Canada: a population-based study
2024, British Journal of CancerIncreasing melanoma incidence and survival trend shifts with improved melanoma-specific survival between 1990 and 2020 in Sweden
2023, British Journal of Dermatology